Second Genome Inc

Second Genome Inc, based in San Francisco, CA, is a pioneering biotechnology company focused on discovering and developing precision therapies that have the potential to transform the field of medicine. With their proprietary platform, Second Genome goes beyond traditional human biology to identify drug targets and therapies, utilizing a suite of proprietary tools and capabilities that enable increased efficiencies, mass data integration, and machine learning identification at the strain level.

The company's advanced pipeline includes lead development candidates SG-5-00455 and SG-3-06686, targeting inflammatory bowel disorders and solid tumors, respectively. With a total of 10 programs in various stages of development, Second Genome is dedicated to advancing precision therapeutics and biomarkers that push the boundaries of human biology and have the potential to revolutionize patient care.

Generated from the website